The Manufacture Data

PCI Pharma Services Unveils Major U.S. Expansion in Sterile Fill-Finish and Drug-Device Capabilities, Supported by Over $1 Billion in Investments

PCI Pharma Services Unveils Major U.S. Expansion in Sterile Fill-Finish and Drug-Device Capabilities, Supported by Over $1 Billion in Investments

A world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers…